Last update : 01/01/2018 | Version : 1 | ID : 104
General | |
Identification | |
Detailed name | Description of the profile of hypertensive patients treated with calcium channel blokers |
Sign or acronym | DECLIC |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL N°9070044 |
General Aspects | |
Medical area |
Cardiology General practice |
Others (details) | high blood pressure |
Keywords | hypertensive patient, calcium channel blockers |
Scientific investigator(s) (Contact) | |
Name of the director | Millet |
Surname | véronique |
Address | 23-25 avenue du Dr Lannelongue, 75668 paris cedex 14 |
Phone | +33 (0)1 58 07 34 12 |
véronique.millet@pfizer.com | |
Unit | Pfizer |
Collaborations | |
Funding | |
Funding status |
Private |
Details | Pfizer |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | Pfizer |
Organisation status |
Private |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Not-repeated cross-sectional studies (except case control studies) |
Database recruitment is carried out by an intermediary |
A selection of health care professionals |
Database recruitment is is made on the basis of: |
Medication(s) taken |
Database recruitment is carried out as part of an interventional study |
No |
Additional information regarding sample selection. | Recruitment through participating doctors |
Database objective | |
Main objective |
Describe the profile and the care for hypertensive patients treated with calcium channel blockers and their distribution according to the level of the cardio-vascular risk as defined by HAS (French National Authority for Health) 2005. - Describe the distribution of the risk factors according to sub-groups of age. - Describe the profile of hypertensive patients on calcium channel blockers according to blood pressure control. - Describe the therapeutic strategy when the high blood pressure is not controlled. |
Inclusion criteria |
Patient over the age of 18 years. - Patient seen through routine liberal medical practice, regardless of the reason for consultation. - Hypertensive patient whether or not balanced, treated with calcium channel blockers in monotherapy or in association. - Patient informed of the objectives of the survey. |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
Population covered |
Sick population |
Gender |
Male Woman |
Geography area |
National |
Detail of the geography area | Metropolitan France |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 2007 |
Date of last collection (YYYY or MM/YYYY) | 2008 |
Size of the database | |
Size of the database (number of individuals) |
[1000-10 000[ individuals |
Details of the number of individuals | 2767 |
Data | |
Database activity |
Data collection completed |
Type of data collected |
Clinical data Declarative data |
Clinical data (detail) |
Direct physical measures Medical registration |
Declarative data (detail) |
Face to face interview |
Presence of a biobank |
No |
Health parameters studied |
Health care consumption and services |
Care consumption (detail) |
Medical/paramedical consultation Medicines consumption |
Procedures | |
Data collection method | Paper CRF |
Participant monitoring |
No |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | methods for accessing the database are currently being defined |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05